Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Text Size
1 study found for:    20008626 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
Conditions: Thrombocytopenia;   MDS;   Myelodysplastic Syndromes;   Refractory Cytopenias
Intervention: Drug: Romiplostim
To Top

† Study has passed its completion date and status has not been verified in more than two years.